On April 1, 2024, 3M completed the separation of its Health Care business through a pro rata distribution of 80.1% of the outstanding shares of Solventum Corporation to 3M stockholders. This resulted in Solventum becoming an independent public company.

3M made certain changes to the composition of segment information reviewed by 3M's chief operating decision maker (CODM) effective in the second quarter of 2024 largely as a result of the separation of Solventum and changes within its business segments effective in the first quarter of 2024.

3M announced in December 2022 that it will exit all PFAS manufacturing by the end of 2025 and is working to discontinue the use of PFAS across its product portfolio by the end of 2025.

3M continues to undertake structural reorganization actions to reduce the size of the corporate center, simplify supply chain, streamline geographic footprint, reduce management layers, and align business go-to-market models. This initiative is expected to impact approximately 8,000 positions worldwide.

3M is taking actions to address PFAS-related liabilities, including those related to site-based contamination, product claims, and litigation matters. 3M has entered into a PWS Settlement and is working to resolve other PFAS-related matters.

3M is managing supply chain and other operational challenges, including those related to supply chain disruptions, higher energy and other commodity costs, lower consumer demand, and changes to foreign exchange rates and financial markets.

3M's results are impacted by worldwide economic, political, regulatory, international trade, geopolitical, and other external conditions, including inflation, recession, military conflicts, and climate change.

3M faces liabilities related to certain fluorochemicals, which could adversely impact its results. The company is also subject to risks related to international, federal, state, and local treaties, laws, and regulations.

3M's results are affected by competitive conditions and customer preferences, and its growth objectives are largely dependent on the timing and market acceptance of its new product offerings.

3M operates in highly competitive markets and faces competition from other manufacturers and suppliers. 3M's ability to maintain its competitive position depends on its ability to innovate, develop new products, and adapt to changing customer preferences.

3M depends on various components, compounds, raw materials, and energy supplied by others. Any sustained interruption in the Company's receipt of adequate supplies or disruption to key manufacturing sites could have a material adverse effect on the Company.

3M relies on patent and other intellectual property protection, and challenges to the Company's intellectual property rights or claims that the Company's activities interfere with the intellectual property rights of a third party, could cause the Company to incur significant expenses.

3M utilizes various tools, such as continuous improvement, to improve productivity and reduce expenses. The company also engages in ongoing global business transformation, including restructurings, to streamline operations and improve efficiency.

3M is managing supply chain challenges, including those related to supply chain disruptions, higher energy and other commodity costs, lower consumer demand, and changes to foreign exchange rates and financial markets.

3M continues to make investments in the implementation of new business systems and solutions, including enterprise resource planning, with these investments impacting cost of sales, SG&A, and R&D.

3M continues to invest in a range of R&D activities from application development, product and manufacturing support, product development and technology development aimed at disruptive innovations.

3M's growth objectives are largely dependent on the timing and market acceptance of its new product offerings, including its ability to continually renew its pipeline of new products and to bring those products to market.

The Company or its third-party vendors may develop or incorporate artificial intelligence technology in certain business processes, services or products. The development and use of artificial intelligence may present risks to the Company's business.

Investing in 3M's business to drive organic growth and deliver strong returns on invested capital remains the first priority for capital deployment. This includes research and development, capital expenditures, and commercialization capability.

3M expects to continue returning cash to shareholders through dividends and share repurchases. In the first nine months of 2024, the Company purchased $1,096 million of its own stock and paid dividends totaling $2.91 per share.

3M is managing its capital structure, including its debt maturities. The Company had no commercial paper outstanding at September 30, 2024, compared to $1.8 billion outstanding as of December 31, 2023.

3M is working to discontinue the use of PFAS across its product portfolio by the end of 2025 and has made progress in eliminating the use of PFAS across its product portfolio in a variety of applications.

3M is taking actions to address PFAS-related liabilities, including those related to site-based contamination, product claims, and litigation matters. 3M has entered into a PWS Settlement and is working to resolve other PFAS-related matters.

In its effort to satisfy its environmental responsibilities and comply with environmental laws and regulations, the Company has established, and periodically updates, policies relating to environmental standards of performance for its operations worldwide.

3M's results are impacted by worldwide economic, political, regulatory, international trade, geopolitical, and other external conditions, including inflation, recession, military conflicts, and climate change.

3M is subject to increasing regulatory scrutiny related to PFAS and other environmental matters. The company is also subject to various other legal and regulatory requirements.

3M's results are affected by competitive conditions and customer preferences, and its growth objectives are largely dependent on the timing and market acceptance of its new product offerings.